Expression control using antibody expression optimisation sequences

Details for Australian Patent Application No. 2006298590 (hide)

Owner UCB Pharma S.A.

Inventors Humphreys, David Paul; Ellis, Mark

Agent Watermark

Pub. Number AU-A-2006298590

PCT Pub. Number WO2007/039714

Priority 0520169.4 04.10.05 GB

Filing date 29 September 2006

Wipo publication date 12 April 2007

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 15/72 (2006.01) Mutation or genetic engineering - Expression systems using regulatory sequences derived from the lac-operon

Event Publications

24 April 2008 PCT application entered the National Phase

  PCT publication WO2007/039714 Priority application(s): WO2007/039714

26 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006298601-Strain-responsive visual indicator

2006298565-Oxycombustion method in which all of the carbon dioxide produced can be captured